These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

339 related items for PubMed ID: 19233146

  • 1. Improvement of depressive behaviors by nefiracetam is associated with activation of CaM kinases in olfactory bulbectomized mice.
    Han F, Nakano T, Yamamoto Y, Shioda N, Lu YM, Fukunaga K.
    Brain Res; 2009 Apr 10; 1265():205-14. PubMed ID: 19233146
    [Abstract] [Full Text] [Related]

  • 2. Nefiracetam activation of CaM kinase II and protein kinase C mediated by NMDA and metabotropic glutamate receptors in olfactory bulbectomized mice.
    Moriguchi S, Han F, Shioda N, Yamamoto Y, Nakajima T, Nakagawasai O, Tadano T, Yeh JZ, Narahashi T, Fukunaga K.
    J Neurochem; 2009 Jul 10; 110(1):170-81. PubMed ID: 19457128
    [Abstract] [Full Text] [Related]

  • 3. Decreased calcium/calmodulin-dependent protein kinase II and protein kinase C activities mediate impairment of hippocampal long-term potentiation in the olfactory bulbectomized mice.
    Moriguchi S, Han F, Nakagawasai O, Tadano T, Fukunaga K.
    J Neurochem; 2006 Apr 10; 97(1):22-9. PubMed ID: 16515554
    [Abstract] [Full Text] [Related]

  • 4. Sigma-1 receptor stimulation by dehydroepiandrosterone ameliorates cognitive impairment through activation of CaM kinase II, protein kinase C and extracellular signal-regulated kinase in olfactory bulbectomized mice.
    Moriguchi S, Yamamoto Y, Ikuno T, Fukunaga K.
    J Neurochem; 2011 Jun 10; 117(5):879-91. PubMed ID: 21434925
    [Abstract] [Full Text] [Related]

  • 5. CaM kinase II and protein kinase C activations mediate enhancement of long-term potentiation by nefiracetam in the rat hippocampal CA1 region.
    Moriguchi S, Shioda N, Han F, Narahashi T, Fukunaga K.
    J Neurochem; 2008 Aug 10; 106(3):1092-103. PubMed ID: 18445137
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. CaMKII activity is essential for improvement of memory-related behaviors by chronic rivastigmine treatment.
    Moriguchi S, Tagashira H, Sasaki Y, Yeh JZ, Sakagami H, Narahashi T, Fukunaga K.
    J Neurochem; 2014 Mar 10; 128(6):927-37. PubMed ID: 24164423
    [Abstract] [Full Text] [Related]

  • 8. Novel nootropic drug sunifiram improves cognitive deficits via CaM kinase II and protein kinase C activation in olfactory bulbectomized mice.
    Moriguchi S, Tanaka T, Tagashira H, Narahashi T, Fukunaga K.
    Behav Brain Res; 2013 Apr 01; 242():150-7. PubMed ID: 23295391
    [Abstract] [Full Text] [Related]

  • 9. Dysregulated CREB signaling pathway in the brain of neural cell adhesion molecule (NCAM)-deficient mice.
    Aonurm-Helm A, Zharkovsky T, Jürgenson M, Kalda A, Zharkovsky A.
    Brain Res; 2008 Dec 03; 1243():104-12. PubMed ID: 18817764
    [Abstract] [Full Text] [Related]

  • 10. A novel cognitive enhancer, ZSET1446/ST101, promotes hippocampal neurogenesis and ameliorates depressive behavior in olfactory bulbectomized mice.
    Shioda N, Yamamoto Y, Han F, Moriguchi S, Yamaguchi Y, Hino M, Fukunaga K.
    J Pharmacol Exp Ther; 2010 Apr 03; 333(1):43-50. PubMed ID: 20068029
    [Abstract] [Full Text] [Related]

  • 11. Nobiletin improves brain ischemia-induced learning and memory deficits through stimulation of CaMKII and CREB phosphorylation.
    Yamamoto Y, Shioda N, Han F, Moriguchi S, Nakajima A, Yokosuka A, Mimaki Y, Sashida Y, Yamakuni T, Ohizumi Y, Fukunaga K.
    Brain Res; 2009 Oct 27; 1295():218-29. PubMed ID: 19646972
    [Abstract] [Full Text] [Related]

  • 12. Changes of learning, memory and levels of CaMKII, CaM mRNA, CREB mRNA in the hippocampus of chronic multiple-stressed rats.
    Sun CY, Qi SS, Lou XF, Sun SH, Wang X, Dai KY, Hu SW, Liu NB.
    Chin Med J (Engl); 2006 Jan 20; 119(2):140-7. PubMed ID: 16454996
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Involvement of a dysfunctional dopamine-D1/N-methyl-d-aspartate-NR1 and Ca2+/calmodulin-dependent protein kinase II pathway in the impairment of latent learning in a model of schizophrenia induced by phencyclidine.
    Mouri A, Noda Y, Noda A, Nakamura T, Tokura T, Yura Y, Nitta A, Furukawa H, Nabeshima T.
    Mol Pharmacol; 2007 Jun 20; 71(6):1598-609. PubMed ID: 17344353
    [Abstract] [Full Text] [Related]

  • 20. Rivastigmine improves hippocampal neurogenesis and depression-like behaviors via 5-HT1A receptor stimulation in olfactory bulbectomized mice.
    Islam MR, Moriguchi S, Tagashira H, Fukunaga K.
    Neuroscience; 2014 Jul 11; 272():116-30. PubMed ID: 24797332
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 17.